Maxcyte (MXCT) Interest Coverage Ratio (2020 - 2026)
Maxcyte's (MXCT) quarterly Interest Coverage Ratio came in at 2.58 in Q1 2026, down 460.58% year-on-year from 0.72 in Q1 2025, and down 1430.0% on a QoQ basis from 0.17 in Q4 2025.
Maxcyte (MXCT) Interest Coverage Ratio (2020 - 2026) Analysis & Trends
Maxcyte (MXCT) has 7 years of Interest Coverage Ratio data on file, last reported at 2.58 in Q1 2026.
- On a quarterly basis, Interest Coverage Ratio fell 460.58% year-over-year to 2.58 in Q1 2026; TTM through Mar 2026 was 19.11, a 896.21% decrease from a year earlier, with the FY2025 full-year figure at 0.78, up 16.41% from the prior year.
- Interest Coverage Ratio for Q1 2026 stood at 2.58, down from 0.17 in the prior quarter.
- Over the last five years, Interest Coverage Ratio for MXCT reached as high as 0.16 in Q1 2022 and fell as low as 7.23 in Q1 2023.
- Historically, Interest Coverage Ratio has averaged 2.35 across 5 years, with a median of 0.53 in 2024.
- Across the five-year window, Interest Coverage Ratio surged 99.99% in 2022 and tumbled 4326.73% in 2023, its largest moves.
- Year by year, Interest Coverage Ratio stood at 0.28 in 2022, then plunged by 80.23% to 0.51 in 2023, then surged by 53.96% to 0.24 in 2024, then gained by 28.24% to 0.17 in 2025, then sank by 1430.0% to 2.58 in 2026.
- Per Business Quant data, the three most recent Interest Coverage Ratio figures were 2.58 in Q1 2026, 0.17 in Q4 2025, and 1.96 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Interest Cover (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.52 Bn | 175.22 Bn | 6.27 Bn | 0.90 |
| 2 | Stryker | 128.96 Bn | 126.09 Bn | 3.81 Bn | 6.32 |
| 3 | Medtronic | 107.99 Bn | 98.77 Bn | 6.41 Bn | 13.19 |
| 4 | Boston Scientific | 67.76 Bn | 66.31 Bn | 3.61 Bn | 2.15 |
| 5 | Edwards Lifesciences | 48.09 Bn | 44.41 Bn | 1.29 Bn | 1.19 |
| 6 | Dexcom | 28.30 Bn | 27.18 Bn | 750.30 Mn | 82.35 |
| 7 | GE HealthCare Technologies | 27.89 Bn | 25.61 Bn | 1.98 Bn | 5.36 |
| 8 | Smith & Nephew | 27.02 Bn | 26.45 Bn | - | - |
| 9 | Koninklijke Philips | 23.98 Bn | 20.86 Bn | 2.07 Bn | -2.90 |
| 10 | Maxcyte | 110.62 Mn | 110.62 Mn | 8.08 Mn | -2.58 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -2.58 |
| Dec 31, 2025 | -0.17 |
| Sep 30, 2025 | -1.96 |
| Jun 30, 2025 | -5.79 |
| Mar 31, 2025 | -0.46 |
| Dec 31, 2024 | -0.24 |
| Sep 30, 2024 | -0.53 |
| Jun 30, 2024 | -0.44 |
| Mar 31, 2024 | -5.38 |
| Dec 31, 2023 | -0.51 |
| Sep 30, 2023 | -1.86 |
| Jun 30, 2023 | -7.17 |
| Mar 31, 2023 | -7.23 |
| Dec 31, 2022 | -0.28 |
| Sep 30, 2022 | -0.31 |
| Jun 30, 2022 | -4.92 |
| Mar 31, 2022 | -0.16 |
| Dec 31, 2021 | 117.98 |
| Sep 30, 2021 | -26.10 |
| Jun 30, 2021 | -21.75 |